http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a0ad9c574cd68362783e07b98f0fac5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Navone |
| name | Nora M. Navone Nora M Navone |
| given-name | Nora M. Nora M |
| organization-name | 1Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Genitourinary Medical Oncology, Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. Department of Genitourinary Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030;; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; 6Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Experimental Therapeutics and 2Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States Department of Genitourinary Medical Oncology Research Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA 5Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas Anderson Cancer Center, Houston, Texas, USA 3Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Pathology, Genitourinary Medical Oncology, Urology and Carcinogenesis, University of Texas, M. D. Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, MD Anderson Cancer Center Department of GU Medical Oncology, University of Texas M. D. Anderson Cancer Center (N.M.N.), Houston, Texas 77030 1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4Genitourinary Medical Oncology, and 1Genitourinary Medical Oncology and Departments of 8Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. David H. Koch Center, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA David H. Koch Center for Applied Research of Genitourinary Cancers The University of Texas MD Anderson Cancer Center Houston Texas Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers The University of Texas MD Anderson Cancer Center Houston Texas USA David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; Authors' Affiliations: 1Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, and Departments of 2Bioinformatics and Computational Biology, 3Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 4Department of Pathology, University of Patras, Patras, Greece Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. nnavone@mdanderson.org. 2Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas and Authors' Affiliations: Departments of 1Genitourinary Medical Oncology; 2Bioinformatics and Computational Biology; 3Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Pathology, University of Patras, Patras; 5Department of Clinical Therapeutics, University of Athens, Athens, Greece; and 6Departament de Biological Chemistry, School of Sciences, University of Buenos Aires, CONICET, Buenos Aires, Argentina 2Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center; MD Anderson Cancer Center Houston Texas |
Incoming Links
Total number of triples: 111.